WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Anna Simonin
Patent Agent
Patents and Innovations
San Francisco
asimonin@wsgr.com

D415-744-4282

Download vCard
Open PDF

Dr. Anna Simonin is a patent agent in the San Francisco office of Wilson Sonsini Goodrich & Rosati. Anna is a member of the patents and innovations practice, where she focuses on patent prosecution, diligence, and intellectual property, particularly in the area of life sciences and biotechnology.

Prior to joining the firm, Anna was an associate director and head of technical documentation at a small biotech company developing live biotherapeutic and small molecule drugs for the treatment of dermatological diseases. She holds a Ph.D. from the University of California, Berkeley, where she studied microbial biology, specifically the genetics and cell biology of hyphal fusion in fungi, and the functional consequences of altering a hyphal network.

Experience

Dr. Anna Simonin is a patent agent in the San Francisco office of Wilson Sonsini Goodrich & Rosati. Anna is a member of the patents and innovations practice, where she focuses on patent prosecution, diligence, and intellectual property, particularly in the area of life sciences and biotechnology.

Prior to joining the firm, Anna was an associate director and head of technical documentation at a small biotech company developing live biotherapeutic and small molecule drugs for the treatment of dermatological diseases. She holds a Ph.D. from the University of California, Berkeley, where she studied microbial biology, specifically the genetics and cell biology of hyphal fusion in fungi, and the functional consequences of altering a hyphal network.

Education
  • Ph.D., Plant Biology, University of California, Berkeley, 2011
  • B.S., Biology, Northern Arizona University, 2003
Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • Ph.D., Plant Biology, University of California, Berkeley, 2011
  • B.S., Biology, Northern Arizona University, 2003
Admissions
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with L.T. Campbell, C. Chen, J. Ferdous, M.P. Padula, E. Harry, M. Hofer, I.L. Campbell, and D.A. Carter, “Cryptococcus strains with different pathogenic potentials have diverse protein secretomes,” 14(6) Eukaryotic Cell 554-63, 2015
  • Co-author with M. Roper, P.C. Hickey, A. Leeder, and N.L. Glass, “Nuclear dynamics in a fungal chimera,” 110(32) Proceedings of the National Academy of Sciences 12875-80, 2013
  • Co-author with J. Palma-Guerrero, M. Fricker, and N.L. Glass, “Physiological significance of network organization in fungi,” 11(11) Eukaryotic Cell 1345-52, 2012
  • Co-author with C.G. Rasmussen, M. Yang, and N.L. Glass, “Genes encoding a striatin-like protein (ham-3) and a forkhead associated protein (ham-4) are required for hyphal fusion in Neurospora crassa,” 47(10) Fungal Genetics and Biology 855-68, 2010
  • Co-author with A. Fleissner and N.L. Glass, “Cell fusion in the filamentous fungus, Neurospora crass,” 475 Methods in Molecular Biology 21-38, 2008
Insights

Select Publications

  • Co-author with L.T. Campbell, C. Chen, J. Ferdous, M.P. Padula, E. Harry, M. Hofer, I.L. Campbell, and D.A. Carter, “Cryptococcus strains with different pathogenic potentials have diverse protein secretomes,” 14(6) Eukaryotic Cell 554-63, 2015
  • Co-author with M. Roper, P.C. Hickey, A. Leeder, and N.L. Glass, “Nuclear dynamics in a fungal chimera,” 110(32) Proceedings of the National Academy of Sciences 12875-80, 2013
  • Co-author with J. Palma-Guerrero, M. Fricker, and N.L. Glass, “Physiological significance of network organization in fungi,” 11(11) Eukaryotic Cell 1345-52, 2012
  • Co-author with C.G. Rasmussen, M. Yang, and N.L. Glass, “Genes encoding a striatin-like protein (ham-3) and a forkhead associated protein (ham-4) are required for hyphal fusion in Neurospora crassa,” 47(10) Fungal Genetics and Biology 855-68, 2010
  • Co-author with A. Fleissner and N.L. Glass, “Cell fusion in the filamentous fungus, Neurospora crass,” 475 Methods in Molecular Biology 21-38, 2008
Focus Areas
  • Biotech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.